Trial
NCT02263547
Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Derrick Scott Robertson
Collaborators
Genzyme, a Sanofi Company; University of South Florida
Condition
Teriflunomide Elimination
Intervention
teriflunomide
Why stopped
PK time points were not being met as expected. Determination that risks outweighed benefit.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-03